OurCrowd (Investment in Biocatch) L.P. — Form D/A
OurCrowd (Investment in Biocatch) L.P. of JERUSALEM, L3, a pooled investment fund, filed a Form D amendment with the SEC on 2024-03-12. $13.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2024-03-12
- Form: D/A
- Accession: 0001607653-24-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Amount sold: $13.0M
- Minimum investment: $10K
- Investors: 244
- Date of first sale: 2023-02-28
- Security types: fund interests
- Revenue range: No Revenues
- SEC file number: 021-476014
Issuer
- Name: OurCrowd (Investment in Biocatch) L.P.
- CIK: 0001607653
- Entity type: Limited Partnership
- Jurisdiction: VIRGIN ISLANDS, BRITISH
- Incorporated: 2017
- Address: 28 DERECH HEBRON, JERUSALEM, L3, 9108001
- Phone: 972-2-636-9300
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Andrew Kaye | Director | Jerusalem, L3 |
| Jonathan Medved | Director | Jerusalem, L3 |
| Caleb Chill | Executive Officer | Jerusalem, L3 |
| Robert Citron | Executive Officer | Jerusalem, L3 |
| Andrew Kaye | Executive Officer | Jerusalem, L3 |
| Jonathan Medved | Executive Officer | Jerusalem, L3 |
| Jay Kalish | Executive Officer | Jerusalem, L3 |
| Steven Blumgart | Director | Jerusalem, L3 |
| Steven Blumgart | Executive Officer | Jerusalem, L3 |
Other filings by this issuer (4)
More